Lori A. Erickson, M.D.

  1. Nguyen AJ, Erickson LA, DiCaudo DJ, Torres-Mora J, Solanki MH, Guo R. Exuberant nodal nevi: study of four cases with the focus on diagnostic pitfall of metastatic melanoma. Hum Pathol 2025 May 9; 105786 Epub 2025 May 09
    View PubMed
  2. Tekin B, Cheville JC, Lucien F, McCarthy M, Dong H, Kopp KJ, Torell NR, Lavoie RR, Farrell A, Jaszewski BL, Smith CY, Jenkins SM, Dasari S, Menon S, Whaley RD, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma. Am J Clin Pathol. 2025 May 6 Epub 2025 May 06
    View PubMed
  3. Torres-Mora J, Whaley RD, Erickson LA. Cauda Equina Neuroendocrine Tumor. Mayo Clin Proc. 2025 May; 100 (5):920-921
    View PubMed
  4. Gupta S, Dasari S, Warren RR, Shen W, Urban RM, Stanton ML, Lohse CM, Holdren MA, Hoenig MF, Pitel BA, Smoley SA, Nelson SW, Torell NR, Moon AC, Nelson LM, Garcia JJ, Lucas PC, Halling KC, Kipp BR, Boorjian SA, De Langhe SP, Erickson LA, Sharma V, Cheville JC, Leibovich BC. Renal Neoplasia in Birt-Hogg-Dube Syndrome: Integrated Histopathologic, Bulk, and Single-cell Transcriptomic Analysis. Eur Urol. 2025 Apr 18 [Epub ahead of print]
    View PubMed
  5. Torres-Mora J, Whaley RD, Erickson LA. Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor (CoGNET). Mayo Clin Proc. 2025 Apr; 100 (4):757-758
    View PubMed
  6. Tekin B, Cheville JC, Enninga EAL, Norgan AP, Johnson EF, Whaley RD, Herrera Hernandez LP, Jimenez RE, Erickson LA, Guo R, Gupta S. P16-Negative, High-Risk Human Papilloma Virus-Associated Penile Squamous Cell Carcinomas. Am J Dermatopathol. 2025 Mar 19 [Epub ahead of print]
    View PubMed
  7. Tekin B, Herrera Hernandez LP, Erickson LA. Verruciform Xanthoma. Mayo Clin Proc. 2025 Mar; 100 (3):579-580
    View PubMed
  8. Tekin B, Guo R, Erickson LA, Cheville JC, Gupta S. Re: p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-Independent Penile Squamous Cell Carcinomas With Adverse Prognosis. Am J Surg Pathol. 2025 Feb 1; 49 (2):189-190 Epub 2024 Sept 26
    View PubMed
  9. Tekin B, Erickson LA, Gupta S. Human Papillomavirus-Associated Penile Squamous Cell Carcinoma. Mayo Clin Proc. 2025 Feb; 100 (2):394-396
    View PubMed
  10. Gupta S, Erickson LA. Metastatic Prostatic Adenocarcinoma With Paneth Cell-Like Neuroendocrine Differentiation. Mayo Clin Proc. 2025 Jan; 100 (1):168-170
    View PubMed
  11. Yang W, Dao LN, Erickson LA. Follicular Lymphoma Presenting in the Small Bowel Mesentery. Mayo Clin Proc. 2024 Dec; 99 (12):2012-2013
    View PubMed
  12. Whaley RD, Gupta S, Manninen MC, O'Brien DR, Erickson LA. Clinicopathologic and Molecular Analysis of 15 Pediatric and Young Adult Patients with High-Grade Non-anaplastic Thyroid Carcinoma. Endocr Pathol. 2024 Dec; 35 (4):397-410 Epub 2024 Dec 05
    View PubMed
  13. Yang W, Gupta S, Erickson LA. Retroperitoneal Lymphadenopathy in a Patient With a History of Multiple Primary Malignant Neoplasms. Mayo Clin Proc. 2024 Nov; 99 (11):1844-1845
    View PubMed
  14. Torres-Mora J, Trejo-Lopez J, Erickson LA. Pseudoendocrine Sarcoma. Mayo Clin Proc. 2024 Oct; 99 (10):1676-1677
    View PubMed
  15. Whaley RD, Erickson LA. Primary Secretory Carcinoma of the Thyroid Gland with ETV6::NTRK3 Gene Fusion. Endocr Pathol. 2024 Sep; 35 (3):274-275 Epub 2024 July 22
    View PubMed
  16. Whaley RD, Folpe AL, Erickson LA. Spindle Epithelial Tumor with Thymus-Like Elements (SETTLE). Endocr Pathol. 2024 Sep; 35 (3):272-273 Epub 2024 July 06
    View PubMed
  17. Torres-Mora J, Erickson LA. CIC-Rearranged Round Cell Sarcoma. Mayo Clin Proc. 2024 Sep; 99 (9):1528-1529
    View PubMed
  18. Gupta S, Erickson LA. Large-Cell Calcifying Sertoli Cell Tumor. Mayo Clin Proc. 2024 Aug; 99 (8):1347-1348
    View PubMed
  19. Tekin B, Cubilla AL, Cheville JC, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Menon S, Whaley RD, Hernandez LH, Jimenez RE, Garcia JJ, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: A single institution experience. Hum Pathol. 2024 Aug; 150:9-19 Epub 2024 June 21
    View PubMed
  20. Torres-Mora J, Gupta S, Erickson LA. Anastomosing Hemangioma of the Adrenal Gland. Mayo Clin Proc. 2024 Jul; 99 (7):1192-1193
    View PubMed
  21. Tekin B, Sali AP, Menon S, Cheville JC, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Cubilla AL, Whaley RD, Hernandez LH, Jimenez RE, Garcia JJ, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Comparison of a modified staging system with 8th edition AJCC criteria in a North American cohort of pT2/pT3 HPV-negative penile squamous cell carcinoma. Hum Pathol. 2024 Jun; 148:81-86 Epub 2024 May 22
    View PubMed
  22. Schembri-Wismayer D, Gupta S, Erickson LA. Cutaneous Adenoid Cystic Carcinoma. Mayo Clin Proc. 2024 Jun; 99 (6):1017-1018
    View PubMed
  23. Tekin B, Gupta S, Erickson LA. Sebaceous Neoplasm With Defective DNA Mismatch Repair. Mayo Clin Proc. 2024 May; 99 (5):846-848
    View PubMed
  24. Tekin B, Erickson LA, Gupta S. Secondary Involvement of the Urinary Bladder by Endometrial Carcinoma. Mayo Clin Proc. 2024 Apr; 99 (4):680-682
    View PubMed
  25. Nath M, Whaley RD, Sukov W, Erickson LA. Primary Multiglandular Parathyroid Disease in the Setting of Pompe Disease. Endocr Pathol. 2024 Mar; 35 (1):88-90 Epub 2024 Mar 02
    View PubMed
  26. Whaley RD, Gupta S, Erickson LA. Oncocytic Poorly Differentiated Thyroid Carcinoma. Mayo Clin Proc. 2024 Mar; 99 (3):511-512
    View PubMed
  27. Whaley RD, Erickson LA. Thyroid Gland Blastomycosis. Endocr Pathol. 2024 Mar; 35 (1):82-83 Epub 2024 Jan 22
    View PubMed
  28. Patil A, Erickson LA, Gupta S. Sporadic Prostate Cancer in a Patient With Lynch Syndrome. Mayo Clin Proc. 2024 Feb; 99 (2):344-345
    View PubMed
  29. Tekin B, Erickson LA, Gupta S. von Hippel-Lindau disease-related neoplasia with an emphasis on renal manifestations. Semin Diagn Pathol. 2024 Jan; 41 (1):20-27 Epub 2023 Nov 08
    View PubMed
  30. Gupta S, Whaley RD, Erickson LA. Pancreatic Neuroendocrine Tumor in a Patient With Multiple Endocrine Neoplasia Type 4. Mayo Clin Proc. 2024 Jan; 99 (1):177-178
    View PubMed
  31. Uccella S, Dottermusch M, Erickson L, Warmbier J, Montone K, Saeger W. Inflammatory and Infectious Disorders in Endocrine Pathology. Endocr Pathol. 2023 Dec; 34 (4):406-436 Epub 2023 May 20
    View PubMed
  32. Tekin B, Cheville JC, Herrera Hernandez L, Negron V, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Menon S, Cubilla AL, Whaley RD, Jimenez RE, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma. Hum Pathol. 2023 Dec; 142:42-50 Epub 2023 Nov 15
    View PubMed
  33. Gupta S, Erickson LA. Metastatic Lung Adenocarcinoma Presenting as Hydrocele. Mayo Clin Proc. 2023 Dec; 98 (12):1894-1896
    View PubMed
  34. Asa SL, Erickson LA, Rindi G. The Spectrum of Endocrine Pathology. Endocr Pathol. 2023 Dec; 34 (4):368-381 Epub 2023 Mar 18
    View PubMed
  35. Whaley RD, Molligan J, Erickson LA. Adrenal Gland Solitary Fibrous Tumor. Mayo Clin Proc. 2023 Nov; 98 (11):1735-1736
    View PubMed
  36. Nath KA, Erickson LA, Garovic VD. Primary and Secondary Diagnoses in Medicine: Insights From Mayo Clinic Consensus Report on Membranous Nephropathy--Executive Summary. Mayo Clin Proc 2023 Nov; 98 (11):1599-1601 Epub 2023 Oct 05
    View PubMed
  37. Gupta S, Swanson AA, Erickson LA. PAX8-Positive (Gynecologic-Type) Clear Cell Carcinoma Metastatic to the Kidney. Mayo Clin Proc. 2023 Oct; 98 (10):1583-1585
    View PubMed
  38. Whaley RD, Gupta S, Erickson LA. Mucoepidermoid Carcinoma. Mayo Clin Proc. 2023 Sep; 98 (9):1427-1428
    View PubMed
  39. Chatzopoulos K, Davila JI, Fadra N, Jackson RA, Minn KT, Sotiriou S, Oliveira AM, Erickson LA, Halling KC, Rumilla KM, Rivera M. Transcriptomic and immunophenotypic characterization of two cases of adamantinoma-like Ewing sarcoma of the thyroid gland. Histopathology. 2023 Sep; 83 (3):426-434 Epub 2023 May 17
    View PubMed
  40. Tekin B, Gilani SI, Dasari S, Theis JD, Rech KL, Dao LN, Cubilla AL, Herrera Hernandez LP, Jimenez RE, Cheville JC, Dispenzieri A, Howard MT, McPhail ED, Erickson LA, Guo R, Gupta S. Proteomic and Clinicopathologic Assessment of Penile Amyloidosis: A Single Institutional Review of 12 Cases. Am J Clin Pathol. 2023 Sep 1; 160 (3):303-313
    View PubMed
  41. Gupta S, Schoolmeester JK, Erickson LA. Gynecologic-Type Adenocarcinoma With Mixed Serous and Endometrioid Features in a Male Patient. Mayo Clin Proc. 2023 Aug; 98 (8):1260-1262
    View PubMed
  42. Gupta S, Norgan AP, Erickson LA. Schistosomiasis of the Urinary Bladder. Mayo Clin Proc. 2023 Jul; 98 (7):1100-1101
    View PubMed
  43. Gupta S, Erickson LA. Papillary Endothelial Hyperplasia. Mayo Clin Proc. 2023 Jun; 98 (6):950-951
    View PubMed
  44. Hopkins M, Gupta S, Erickson LA. Perianal Treponema pallidum. Mayo Clin Proc. 2023 May; 98 (5):807-809
    View PubMed
  45. Tekin B, Guo R, Cheville JC, Canete-Portillo S, Sanchez DF, Fernandez-Nestosa MJ, Dasari S, Menon S, Herrera-Hernandez L, Jimenez RE, Erickson LA, Cubilla AL, Gupta S. Penile squamous cell carcinoma exclusive to the shaft, with a proposal for a novel staging system. Hum Pathol. 2023 Apr; 134:92-101 Epub 2022 Dec 23
    View PubMed
  46. McCarthy MR, Gupta S, Erickson LA. Acquired Cystic Disease-Associated Renal Cell Carcinoma. Mayo Clin Proc. 2023 Apr; 98 (4):637-638
    View PubMed
  47. Erickson LA, Rivera M, Guo R, Torres-Mora J, Gupta S. Thyroblastoma-a Primitive Multilineage Thyroid Neoplasm with Somatic DICER1 Alteration. Endocr Pathol. 2023 Mar; 34 (1):159-160 Epub 2023 Feb 15
    View PubMed
  48. Gupta S, Erickson LA. Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas. Surg Pathol Clin. 2023 Mar; 16 (1):119-129
    View PubMed
  49. Erickson LA, Gupta S, Torres-Mora J. Hepatic Hemangioma. Mayo Clin Proc. 2023 Mar; 98 (3):489-491
    View PubMed
  50. Torbenson M, Venkatesh SK, Halfdanarson TR, Navin PJ, Kamath P, Erickson LA. Primary neuroendocrine tumors and primary neuroendocrine carcinomas of the liver: a proposal for a multidiscipline definition. Hum Pathol. 2023 Feb; 132:77-88 Epub 2022 July 06
    View PubMed
  51. Erickson LA, Whaley RD, Gupta S. Adrenal Epithelial Cysts. Mayo Clin Proc. 2023 Feb; 98 (2):353-354
    View PubMed
  52. Dehner CA, Torres-Mora J, Erickson LA. Mesenchymal Neoplasm With ACTB-GLI1 Fusion in an Individual With Neurofibromatosis Type 1. Mayo Clin Proc. 2023 Jan; 98 (1):206-207
    View PubMed
  53. Gupta S, Erickson LA. The Cytogenetic Profile of Spindle Cell-Predominant Mucinous Tubular and Spindle Cell Carcinoma. Mayo Clin Proc. 2022 Dec; 97 (12):2387-2388
    View PubMed
  54. McCarthy M, Whaley RD, Erickson LA. Oncocytic Parathyroid Adenoma. Mayo Clin Proc. 2022 Nov; 97 (11):2168-2169
    View PubMed
  55. Geiersbach KB, Gliem TJ, Jenkins SM, Gaitatzes AG, Brodersen PR, Negro ME, Clees MJ, Swanson KE, Boeckman RM, Natrop TJ, Sukov WR, Shah KK, Greipp PT, Rowsey RA, Flotte TJ, Erickson LA, Guo R. Single-Nucleotide Polymorphism Array for Histologically Ambiguous Melanocytic Tumors. J Mol Diagn. 2022 Nov; 24 (11):1160-1170 Epub 2022 Sept 14
    View PubMed
  56. Gupta S, Erickson LA. Prepubertal-Type Testicular Tumors in Postpubertal Patients: Epidermoid Cyst and Well-Differentiated Neuroendocrine Tumor. Mayo Clin Proc. 2022 Oct; 97 (10):1956-1957
    View PubMed
  57. Shakshouk H, Erickson LA, Johnson EF, Lehman JS. Updates and Proposed Diagnostic Approach to Psoriasiform Dermatoses. Adv Anat Pathol. 2022 Sep 1; 29 (5):263-274 Epub 2022 Feb 18
    View PubMed
  58. Chen B, Guo R, Erickson LA. Anastomosing Hemangioma. Mayo Clin Proc. 2022 Sep; 97 (9):1756-1757
    View PubMed
  59. Gupta S, Guo R, Erickson LA. Anaplastic Thyroid Carcinoma, Squamous Cell Carcinoma Pattern. Mayo Clin Proc. 2022 Aug; 97 (8):1584-1585
    View PubMed
  60. Gupta S, Erickson LA. Postirradiation Angiosarcoma of the Urinary Bladder. Mayo Clin Proc. 2022 Jul; 97 (7):1406-1408
    View PubMed
  61. Gupta S, Herrera-Hernandez L, Erickson LA. Amyloid Involving the Seminal Vesicles. Mayo Clin Proc. 2022 Jun; 97 (6):1213-1214
    View PubMed
  62. Gupta S, Erickson LA. Papillary Renal Cell Carcinoma With "Drop Metastasis" (Tumor Seeding) Involving the Distal Ureter. Mayo Clin Proc. 2022 May; 97 (5):1026-1028
    View PubMed
  63. Erickson LA, Gupta S. STAT6 Immunopositivity in Solitary Fibrous Tumor of Thyroid Gland. Mayo Clin Proc. 2022 Apr; 97 (4):808-810
    View PubMed
  64. Gupta S, Swanson AA, Erickson LA. Renal Cell Carcinoma With Combined Loss of Fumarate Hydratase and SMARCB1/INI-1. Mayo Clin Proc. 2022 Mar; 97 (3):630-632
    View PubMed
  65. Nose V, Gill A, Teijeiro JMC, Perren A, Erickson L. Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes. Endocr Pathol. 2022 Mar; 33 (1):197-227 Epub 2022 Mar 13
    View PubMed
  66. Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, Papotti MG. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr Pathol. 2022 Mar; 33 (1):155-196 Epub 2022 Mar 14
    View PubMed
  67. Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ. Overview of the 2022 WHO Classification of Parathyroid Tumors. Endocr Pathol. 2022 Mar; 33 (1):64-89 Epub 2022 Feb 17
    View PubMed
  68. Torbenson MS, Erickson LA. Hemochromatosis. Mayo Clin Proc. 2022 Feb; 97 (2):423-424
    View PubMed
  69. Erickson LA, Chen B. Desmoid Tumor and Multiple Colon Adenomas. Mayo Clin Proc. 2022 Jan; 97 (1):193-195
    View PubMed
  70. Slostad JA, Liu MC, Allred JB, Erickson LA, Rumilla KM, Block MS, Keppen M, King D, Markovic SN, McWilliams RR. BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance). Mayo Clin Proc Innov Qual Outcomes. 2021 Dec; 5 (6):1012-1020 Epub 2021 Oct 13
    View PubMed
  71. Erickson LA. Adrenal Myelolipoma. Mayo Clin Proc. 2021 Dec; 96 (12):3186-3187
    View PubMed
  72. Schoolmeester JK, Schembri-Wismayer D, Erickson LA. Uterine Epithelioid Trophoblastic Tumor. Mayo Clin Proc. 2021 Nov; 96 (11):2925-2926
    View PubMed
  73. Gupta S, Erickson LA, Lohse CM, Shen W, Pitel BA, Knight SM, Halling KC, Herrera-Hernandez L, Boorjian SA, Thompson RH, Leibovich BC, Jimenez RE, Cheville JC. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia. JAMA Netw Open. 2021 Nov 1; 4 (11):e2132615 Epub 2021 Nov 01
    View PubMed
  74. Gupta S, Erickson LA. Renal Neoplasia in Hyperparathyroidism-Jaw Tumor Syndrome. Mayo Clin Proc. 2021 Oct; 96 (10):2730-2731
    View PubMed
  75. Nisar US, Erickson LA, Folpe AL, Hartley CP, Littrell LA, Adamo DA, Sturgis CD. Eccrine angiomatous hamartoma: First case in the cytology literature. Ann Diagn Pathol. 2021 Oct; 54:151796 Epub 2021 July 17
    View PubMed
  76. Chen B, Erickson LA. Metaplastic Breast Cancer. Mayo Clin Proc. 2021 Sep; 96 (9):2498-2499
    View PubMed
  77. Erickson LA. Sebaceous Carcinoma. Mayo Clin Proc. 2021 Aug; 96 (8):2285-2287
    View PubMed
  78. Erickson LA. Anaplastic Thyroid Carcinoma. Mayo Clin Proc. 2021 Jul; 96 (7):2008-2011
    View PubMed
  79. Gupta S, Erickson LA. Primary Renal Well-Differentiated Neuroendocrine Tumor (Carcinoid) in a Horseshoe Kidney. Mayo Clin Proc. 2021 Jun; 96 (6):1687-1688
    View PubMed
  80. Erickson LA. Angiosarcoma of the Adrenal Gland. Mayo Clin Proc. 2021 May; 96 (5):1376-1378
    View PubMed
  81. Williams MD, DeLellis RA, Erickson LA, Gupta R, Johnson SJ, Kameyama K, Natu S, Ng T, Perren A, Perrier ND, Seethala RR, Gill AJ. Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol. 2021 Apr; 110:73-82 Epub 2020 July 17
    View PubMed
  82. Chen B, Erickson LA. Juvenile Papillomatosis of Breast. Mayo Clin Proc. 2021 Apr; 96 (4):1097-1098
    View PubMed
  83. Giordano TJ, Berney D, de Krijger RR, Erickson L, Fassnacht M, Mete O, Papathomas T, Papotti M, Sasano H, Thompson LDR, Volante M, Gill AJ. Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Hum Pathol. 2021 Apr; 110:50-61 Epub 2020 Oct 12
    View PubMed
  84. Gupta S, Erickson LA. Paratesticular Papillary Cystadenoma of the Epididymis in the Setting of von Hippel-Lindau. Mayo Clin Proc. 2021 Mar; 96 (3):828-829
    View PubMed
  85. Juhlin CC, Erickson LA. Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice. Endocr Pathol. 2021 Mar; 32 (1):17-34 Epub 2020 Dec 02
    View PubMed
  86. Erickson LA. Pheochromocytoma in Multiple Endocrine Neoplasia Type 2. Mayo Clin Proc. 2021 Feb; 96 (2):511-512
    View PubMed
  87. Erickson LA, Chen B. Papillary Thyroid Carcinoma BRAF Immunopositivity. Mayo Clin Proc. 2021 Jan; 96 (1):267-268
    View PubMed
  88. Gupta S, Erickson LA. Renal Neoplasia in Cowden Syndrome. Mayo Clin Proc. 2020 Dec; 95 (12):2808-2809
    View PubMed
  89. Zarei S, Voss JS, Jin L, Jenkins SM, Bryce AH, Erickson LA, Bell DA, Kipp BR, Flotte TJ. Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site. Int J Gynecol Pathol. 2020 Nov; 39 (6):587-594
    View PubMed
  90. Erickson LA, Chen B. Fibroadenoma of the Breast. Mayo Clin Proc. 2020 Nov; 95 (11):2573-2574
    View PubMed
  91. Shah KK, Neff JL, Erickson LA, Jackson RA, Jenkins SM, Mansfield AS, Moser JC, Harris AL, Copland JA, Halling KC, Flotte TJ. Correlation of novel ALK(ATI) with ALK immunohistochemistry and clinical outcomes in metastatic melanoma. Histopathology. 2020 Oct; 77 (4):601-610 Epub 2020 Sept 15
    View PubMed
  92. Schoolmeester JK, Erickson LA. High-Grade Serous Carcinoma of the Fallopian Tube. Mayo Clin Proc. 2020 Oct; 95 (10):2300-2301
    View PubMed
  93. Guo R, Chen B, Erickson LA. Mucinous Carcinoma of the Breast. Mayo Clin Proc. 2020 Sep; 95 (9):2049-2050
    View PubMed
  94. Erickson LA. Hyalinizing Trabecular Tumor of the Thyroid. Mayo Clin Proc. 2020 Aug; 95 (8):1810-1811
    View PubMed
  95. Erickson LA, Torbenson MS. Hepatic Focal Nodular Hyperplasia. Mayo Clin Proc. 2020 Jul; 95 (7):1557-1558
    View PubMed
  96. Erickson LA. Fibrolamellar Carcinoma. Mayo Clin Proc. 2020 Jun; 95 (6):1298-1299
    View PubMed
  97. Gupta S, Erickson LA. Tuberous Sclerosis-Associated Renal Neoplasm. Mayo Clin Proc. 2020 May; 95 (5):1089-1090
    View PubMed
  98. Erickson LA. Unique Clinical Significance of the Cribriform-Morular Variant of Papillary Thyroid Carcinoma. Mayo Clin Proc. 2020 Apr; 95 (4):831-833
    View PubMed
  99. Gupta S, Erickson LA. Fumarate Hydratase-Deficient Renal Cell Carcinoma. Mayo Clin Proc. 2020 Mar; 95 (3):619-621
    View PubMed
  100. Erickson LA, Torbenson MS. Intestinal Spirochetosis. Mayo Clin Proc. 2020 Feb; 95 (2):427-428
    View PubMed
  101. Markovic SN, Suman VJ, Javed A, Reid JM, Wall DJ, Erickson LA, Ernstoff M, Anderson DM. Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU) RU261206I. Am J Clin Oncol. 2020 Feb; 43 (2):115-121
    View PubMed
  102. Erickson LA. Malignant Epithelioid Angiomyolipoma of the Kidney (Malignant Perivascular Epithelioid Cell Neoplasm). Mayo Clin Proc. 2020 Jan; 95 (1):205-206
    View PubMed
  103. Erickson LA. Merkel Cell Carcinoma. Mayo Clin Proc. 2019 Dec; 94 (12):2602-2604
    View PubMed
  104. Erickson LA. Soft Tissue Leiomyosarcoma. Mayo Clin Proc. 2019 Nov; 94 (11):2366-2367
    View PubMed
  105. Schoolmeester JK, Erickson LA. Uterine Leiomyoma. Mayo Clin Proc. 2019 Oct; 94 (10):2150-2151
    View PubMed
  106. Schoolmeester JK, Erickson LA. Renal Leiomyoma. Mayo Clin Proc. 2019 Sep; 94 (9):1913-1914
    View PubMed
  107. Schoolmeester JK, Erickson LA. Ovarian Fibrothecoma. Mayo Clin Proc. 2019 Aug; 94 (8):1652-1653
    View PubMed
  108. Erickson LA, Inwards CY. Multiple Hereditary Osteochondromas. Mayo Clin Proc. 2019 Jul; 94 (7):1388-1389
    View PubMed
  109. Guo R, Erickson LA. Thymoma. Mayo Clin Proc. 2019 Jun; 94 (6):1122-1123
    View PubMed
  110. Erickson LA. Splenic Hemangioma. Mayo Clin Proc. 2019 May; 94 (5):926-927
    View PubMed
  111. Erickson LA. Spermatic Cord Liposarcoma. Mayo Clin Proc. 2019 Apr; 94 (4):737-738
    View PubMed
  112. Erickson LA. Posterior Mediastinal Schwannoma (Neurilemmoma). Mayo Clin Proc. 2019 Mar; 94 (3):559-560
    View PubMed
  113. Guo R, Erickson LA. Gastrointestinal Stromal Tumor. Mayo Clin Proc. 2019 Feb; 94 (2):373-374
    View PubMed
  114. Erickson LA. Lipoma. Mayo Clin Proc. 2019 Jan; 94 (1):176-177
    View PubMed
  115. Yasir S, Erickson LA. Intracholecystic Papillary-Tubular Neoplasm of the Gallbladder. Mayo Clin Proc. 2018 Dec; 93 (12):1883-1884
    View PubMed
  116. Dao LN, Erickson LA. Classic Hodgkin Lymphoma. Mayo Clin Proc. 2018 Nov; 93 (11):1692-1693
    View PubMed
  117. Shah K, Yi ES, Erickson LA. Solitary Lung Nodule. Mayo Clin Proc. 2018 Oct; 93 (10):1533-1534
    View PubMed
  118. Li AM, Erickson LA. Diabetic Mastopathy. Mayo Clin Proc. 2018 Sep; 93 (9):1334-1335
    View PubMed
  119. Erickson LA. Lung Adenocarcinoma. Mayo Clin Proc. 2018 Aug; 93 (8):1153-1154
    View PubMed
  120. Vera Aguilera J, Rao RD, Allred JB, Suman VJ, Windschitl HE, Kaur JS, Maples WJ, Lowe VJ, Creagan ET, Erickson LA, Markovic S. Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance). Oncologist. 2018 Aug; 23 (8):887-e94 Epub 2018 Apr 17
    View PubMed
  121. Markovic SN, Galli F, Suman VJ, Nevala WK, Paulsen AM, Hung JC, Gansen DN, Erickson LA, Marchetti P, Wiseman GA, Signore A. Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot study. Oncotarget. 2018 Jul 13; 9(54):30268-30278.
    View PubMed
  122. Erickson LA. Endometrial Adenocarcinoma, Endometrioid Type. Mayo Clin Proc. 2018 Jul; 93 (7):963-964
    View PubMed
  123. Erickson LA. Clear Cell Renal Cell Carcinoma. Mayo Clin Proc. 2018 Jun; 93 (6):813-814
    View PubMed
  124. Erickson LA, Mete O. Immunohistochemistry in Diagnostic Parathyroid Pathology. Endocr Pathol. 2018 Jun; 29 (2):113-129
    View PubMed
  125. Nath MC, Erickson LA. Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid. Adv Anat Pathol. 2018 May; 25 (3):172-179
    View PubMed
  126. Erickson LA. Adenocarcinoma of the Colon and Microsatellite Instability. Mayo Clin Proc. 2018 May; 93 (5):669-670
    View PubMed
  127. Nath MC, Torbenson MS, Erickson LA. Desmoid Tumor. Mayo Clin Proc. 2018 Apr; 93 (4):549-550
    View PubMed
  128. Nath MC, Torbenson MS, Erickson LA. Perihilar Cholangiocarcinoma. Mayo Clin Proc. 2018 Mar; 93 (3):397-398
    View PubMed
  129. McWilliams RR, Allred JB, Slostad JA, Katipamula R, Dronca RS, Rumilla KM, Erickson LA, Bryce AH, Joseph RW, Kottschade LA, King DM, Leitch JM, Markovic SN. NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab +/- everolimus for metastatic melanoma. Cancer. 2018 Feb 1; 124 (3):537-545 Epub 2017 Oct 17
    View PubMed
  130. Erickson LA, Rivera M. Mucinous Neoplasm of the Appendix and Pseudomyxoma Peritonei. Mayo Clin Proc. 2018 Feb; 93 (2):267-268
    View PubMed
  131. Erickson LA. Challenges in surgical pathology of adrenocortical tumours. Histopathology. 2018 Jan; 72 (1):82-96
    View PubMed
  132. Blessing MM, Raghunathan A, Erickson LA. Progressive Multifocal Leukoencephalopathy. Mayo Clin Proc. 2018 Jan; 93 (1):123-125
    View PubMed
  133. Erickson LA. Ductal Carcinoma in Situ of the Breast. Mayo Clin Proc. 2017 Dec; 92 (12):1873-1874
    View PubMed
  134. Ambrosi F, Righi A, Ricci C, Erickson LA, Lloyd RV, Asioli S. Hobnail Variant of Papillary Thyroid Carcinoma: a Literature Review. Endocr Pathol. 2017 Dec; 28 (4):293-301
    View PubMed
  135. Schoolmeester JK, Erickson LA. Gestational Trophoblastic Disease. Mayo Clin Proc. 2017 Nov; 92 (11):1739-1740 Epub 2017 Nov 01
    View PubMed
  136. Erickson LA. Renal Pyelocalyceal Squamous Cell Carcinoma. Mayo Clin Proc. 2017 Oct; 92 (10):1603-1604
    View PubMed
  137. Erickson LA. Pancreatic Ductal Adenocarcinoma. Mayo Clin Proc. 2017 Sep; 92 (9):1461-1462
    View PubMed
  138. Domingo-Musibay E, Heun JM, Nevala WK, Callstrom M, Atwell T, Galanis E, Erickson LA, Markovic SN. Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma. Oncologist. 2017 Sep; 22 (9):1026-e93 Epub 2017 July 05
    View PubMed
  139. Gupta S, Zhang J, Milosevic D, Mills JR, Grebe SK, Smith SC, Erickson LA. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). Endocr Pathol. 2017 Sep; 28 (3):253-268
    View PubMed
  140. Gupta S, Zhang J, Erickson LA. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase. Endocr Pathol. 2017 Sep; 28 (3):269-275
    View PubMed
  141. Erickson LA. Hepatocellular Carcinoma. Mayo Clin Proc. 2017 Aug; 92 (8):1321-1322
    View PubMed
  142. Erickson LA. Squamous Cell Carcinoma of the Tongue. Mayo Clin Proc. 2017 Jul; 92 (7):1171-1172
    View PubMed
  143. Bridges AG, Erickson LA. Co-occurrence of steatocystoma multiplex, eruptive vellus hair cysts, and trichofolliculomas. Cutis. 2017 Jul; 100 (1):E23-E26
    View PubMed
  144. Erickson LA. Gastric Signet Ring Cell Carcinoma. Mayo Clin Proc. 2017 Jun; 92 (6):e95-e96
    View PubMed
  145. Erickson LA. Mantle Cell Involvement of the Spleen. Mayo Clin Proc. 2017 May; 92 (5):e81-e82
    View PubMed
  146. Erickson LA. Branchial Cleft Cyst in Lateral Neck of an Adult. Mayo Clin Proc. 2017 Apr; 92 (4):e69-e70
    View PubMed
  147. Erickson LA. Pleomorphic Adenoma in the Parotid Gland. Mayo Clin Proc. 2017 Mar; 92 (3):e55-e56
    View PubMed
  148. Gupta S, Erickson LA. Testicular Seminoma. Mayo Clin Proc. 2017 Feb; 92 (2):e21-e22
    View PubMed
  149. Erickson LA. Familial disorders of parathyroid glands Diagnostic Histopathology. 2017; 23: (8)359-65.
  150. Schoolmeester JK, Erickson LA. Cervical Minimal Deviation Adenocarcinoma in Peutz-Jeghers Syndrome. Mayo Clin Proc. 2017 Jan; 92 (1):e7-e8
    View PubMed
  151. Gupta S, Erickson LA. Paratesticular Adenomatoid Tumor. Mayo Clin Proc. 2016 Dec; 91 (12):e167-e168
    View PubMed
  152. Vaubel RA, Raghunathan A, Erickson LA. Parkinson Disease. Mayo Clin Proc. 2016 Nov; 91 (11):e155-e156
    View PubMed
  153. Romano RC, Bois MC, Erickson LA. Sacral Chordoma. Mayo Clin Proc. 2016 Oct; 91 (10):e143-e144
    View PubMed
  154. Sandell RF, Erickson LA. Diffuse Large B-cell Lymphoma of the Testis. Mayo Clin Proc. 2016 Sep; 91 (9):e131-2
    View PubMed
  155. Lee HE, Mounajjed T, Erickson LA, Wu TT. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index. Endocr Pathol. 2016 Sep; 27 (3):259-67
    View PubMed
  156. Gupta S, Zhang J, Rivera M, Erickson LA. Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome. Endocr Pathol. 2016 Sep; 27 (3):243-52
    View PubMed
  157. Jentoft ME, Erickson LA. Alzheimer Disease. Mayo Clin Proc. 2016 Aug; 91 (8):e117-8
    View PubMed
  158. Rule WG, Allred JB, Pockaj BA, Markovic SN, DiCaudo DJ, Erickson LA, Deming RL, Schild SE. Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma. Cancer Med. 2016 Aug; 5 (8):1890-6 Epub 2016 July 01
    View PubMed
  159. Jentoft ME, Erickson LA. Alzheimer disease Mayo Clinic Proceedings. 2016 Aug; 91(8):E117-8. Epub 1900 Jan 01.
  160. Hung T, Argenyi Z, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Piepkorn MW, Prieto VG, Rabkin MS, Schmidt B, Selim MA, Shea CR, Trotter MJ, Barnhill RL. Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases. Am J Dermatopathol. 2016 Jul; 38: (7)499-503.
    View PubMed
  161. Carter JM, Erickson LA. An Adult Male With Hypophosphatemic Osteomalacia. Mayo Clin Proc. 2016 Jun; 91 (6):e81-2
    View PubMed
  162. Papathomas TG, Pucci E, Giordano TJ, Lu H, Duregon E, Volante M, Papotti M, Lloyd RV, Tischler AS, van Nederveen FH, Nose V, Erickson L, Mete O, Asa SL, Turchini J, Gill AJ, Matias-Guiu X, Skordilis K, Stephenson TJ, Tissier F, Feelders RA, Smid M, Nigg A, Korpershoek E, van der Spek PJ, Dinjens WN, Stubbs AP, de Krijger RR. An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma. Am J Surg Pathol. 2016 Apr; 40 (4):569-76
    View PubMed
  163. Lehrke HD, Torbenson MS, Erickson LA. Man With Fever and Severe Diarrhea. Mayo Clin Proc. 2016 Apr; 91 (4):e55-6
    View PubMed
  164. Gupta S, Herrera Hernandez LP, Erickson LA. Diagnosing a Kidney Tumor. Mayo Clin Proc. 2016 Mar; 91: (3)e41-2.
    View PubMed
  165. Gupta S, Erickson LA. Young Female Patient With a Hepatic Adenoma: Determining Risk for Malignant Transformation. Mayo Clin Proc. 2016 Feb; 91: (2)e29-30.
    View PubMed
  166. Vaubel RA, Raghunathan A, Erickson LA. Parkinson disease Mayo Clinic Proceedings. 2016; 91(11):e155-6. Epub 1900 Jan 01.
  167. Gupta S, Erickson LA. Pancreatic Tumor in a Patient With Parathyroid and Pituitary Disease. Mayo Clin Proc. 2016 Jan; 91 (1):e17-8
    View PubMed
  168. Erickson LA, Vrana JA, Theis J, Rivera M, Lloyd RV, McPhail E, Zhang J. Analysis of Amyloid in Medullary Thyroid Carcinoma by Mass Spectrometry-Based Proteomic Analysis. Endocr Pathol. 2015 Dec; 26 (4):291-5
    View PubMed
  169. Erickson LA, Highsmith WE Jr, Fei P, Zhang J. Targeting the hypoxia pathway to treat pancreatic cancer. Drug Des Devel Ther. 2015; 9:2029-31 Epub 2015 Apr 08
    View PubMed
  170. Jin L, Lloyd RV, Henry MR, Erickson LA, Sebo TJ, Rumilla KM, Zhang J. The diagnostic utility of combination of HMGA2 and IMP3 qRT-PCR testing in thyroid neoplasms. Appl Immunohistochem Mol Morphol. 2015 Jan; 23 (1):36-43
    View PubMed
  171. Kottschade LA, Grotz TE, Dronca RS, Salomao DR, Pulido JS, Wasif N, Jakub JW, Bagaria SP, Kumar R, Kaur JS, Morita SY, Moran SL, Nguyen JT, Nguyen EC, Hand JL, Erickson LA, Brewer JD, Baum CL, Miller RC, Swanson DL, Lowe V, Markovic SN. Rare presentations of primary melanoma and special populations: a systematic review. Am J Clin Oncol. 2014 Dec; 37 (6):635-41
    View PubMed
  172. Erickson LA, Rivera M, Zhang J. Adrenocortical carcinoma: review and update. Adv Anat Pathol. 2014 May; 21(3):151-9.
    View PubMed
  173. Jin L, Lloyd RV, Henry MR, Erickson LA, Sebo TJ, Rumilla KM, Zhang J. The diagnostic utility of combination of HMGA2 and IMP3 qRT-PCR testing in thyroid neoplasms. Applied Immunohistochemistry and Molecular Morphology. 2014; 23(1):36-43.
  174. Asioli S, Erickson LA, Righi A, Lloyd RV. Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol. 2013 Mar; 44(3):320-8. Epub 2012 Oct 1.
    View PubMed
  175. Thomas L, Moore EJ, McGree ME, Olsen KD, Kasperbauer JL, Erickson LA, Schembri-Wismayer DJ. Prognostic features, human papillomavirus status, and epidermal growth factor receptor expression in oral squamous cell carcinoma in young adults. Am J Otolaryngol. 2012 Nov-Dec; 33(6):650-6. Epub 2012 Mar 03.
    View PubMed
  176. Grotz TE, Mansfield AS, Kottschade LA, Erickson LA, Otley CC, Markovic SN, Jakub JW. In-transit melanoma: an individualized approach. Oncology (Williston Park). 2011 Dec; 25(14):1340-8.
    View PubMed
  177. Palmer SR, Erickson LA, Ichetovkin I, Knauer DJ, Markovic SN. Circulating serologic and molecular biomarkers in malignant melanoma. Mayo Clin Proc. 2011 Oct; 86 (10):981-90
    View PubMed
  178. Grotz TE, Markovic SN, Erickson LA, Harmsen WS, Huebner M, Farley DR, Pockaj BA, Donohue JH, Sim FH, Grant CS, Bagaria SP, Shives TC, Balch CM, Jakub JW, Mayo Clinic. Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma. Mayo Clin Proc. 2011 Jun; 86 (6):522-8
    View PubMed
  179. Wada DA, Law ME, Hsi ED, Dicaudo DJ, Ma L, Lim MS, Souza Ad, Comfere NI, Weenig RH, Macon WR, Erickson LA, Ozsan N, Ansell SM, Dogan A, Feldman AL. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod Pathol. 2011 Apr; 24(4):596-605. Epub 2010 Dec 17.
    View PubMed
  180. Mansfield AS, Holtan SG, Grotz TE, Allred JB, Jakub JW, Erickson LA, Markovic SN. Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis. Mod Pathol. 2011 Apr; 24 (4):487-94 Epub 2010 Dec 10
    View PubMed
  181. Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, Papotti M, Bussolati G, Lloyd RV. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol. 2010 Sep; 23 (9):1269-78 Epub 2010 June 18
    View PubMed
  182. Wood A, Markovic SN, Best PJ, Erickson LA. Metastatic malignant melanoma manifesting as an intracardiac mass. Cardiovasc Pathol. 2010 May-Jun; 19(3):153-7. Epub 2009 Feb 11.
    View PubMed
  183. Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010 Jan; 34 (1):44-52
    View PubMed
  184. Cradic KW, Milosevic D, Rosenberg AM, Erickson LA, McIver B, Grebe SK. Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status. J Clin Endocrinol Metab. 2009 Dec; 94 (12):5001-9 Epub 2009 Oct 22
    View PubMed
  185. Asioli S, Erickson LA, Lloyd RV. Solid cell nests in Hashimoto's thyroiditis sharing features with papillary thyroid microcarcinoma. Endocr Pathol. 2009 Winter; 20 (4):197-203
    View PubMed
  186. Erickson LA, Letts GA, Shah SM, Shackelton JB, Duncan LM. TRPM1 (Melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas. Mod Pathol. 2009 Jul; 22(7):969-76. Epub 2009 Apr 24.
    View PubMed
  187. Feldman AL, Law M, Remstein ED, Macon WR, Erickson LA, Grogg KL, Kurtin PJ, Dogan A. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia. 2009 Mar; 23 (3):574-80 Epub 2008 Nov 06
    View PubMed
  188. Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR, Melanoma Study. Metastatic malignant melanoma. G Ital Dermatol Venereol. 2009 Feb; 144(1):1-26.
    View PubMed
  189. Rumilla KM, Erickson LA, Service FJ, Vella A, Thompson GB, Grant CS, Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression. Mod Pathol. 2009 Feb; 22 (2):239-45 Epub 2008 Oct 17
    View PubMed
  190. Erickson LA, Lloyd RV. Familial disorders of the parathyroid gland. Diagn Histopathol. 2009; 15(2):79-86.
  191. Rodriguez FJ, Scheithauer BW, Erickson LA, Jenkins RB, Giannini C. Ectopic low-grade adrenocortical carcinoma in the spinal region: immunohistochemical and molecular cytogenetic study of a pediatric case. Am J Surg Pathol. 2009 Jan; 33 (1):142-8
    View PubMed
  192. Markovic SN, Suman VJ, Nevala WK, Geeraerts L, Creagan ET, Erickson LA, Rowland KM Jr, Morton RF, Horvath WL, Pittelkow MR. A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study. Am J Clin Oncol. 2008 Dec; 31 (6):573-9
    View PubMed
  193. Sadow PM, Rumilla KM, Erickson LA, Lloyd RV. Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors. Endocr Pathol. 2008 Summer; 19(2):97-103.
    View PubMed
  194. Grogg KL, Jung S, Erickson LA, McClure RF, Dogan A. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol. 2008 Jun; 21 (6):708-15 Epub 2008 Feb 29
    View PubMed
  195. Markovic S, Suman V, Nevala W, Geeraerts L, Pittelkow M, Ingle J, Creagan E, Kaur J, Erickson L, Rowland K, Morton R, Horvath W. Autologous Anti-Tumor Immunization: A Dose-Escalation Study of Aerosolized Sargramostim (Granulocyte Macrophage Colony Stimulating Factor) in the Treatment of Metastatic Melanoma to the Lung. Am J Clin Oncol. 2008; 31:573-9.
  196. Barnhill RL, Argenyi Z, Berwick M, Duray PH, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Paine S, Piepkorn MW, Prieto V, Rabkin MS, Schmidt B, Selim A, Shea CR, Trotter MJ. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). Am J Surg Pathol. 2008 Jan; 32(1):36-44.
    View PubMed
  197. Stilling GA, Zhang H, Ruebel KH, Leontovich AA, Jin L, Tanizaki Y, Zhang S, Erickson LA, Hobday T, Lloyd RV. Characterization of the functional and growth properties of cell lines established from ileal and rectal carcinoid tumors. Endocr Pathol. 2007 Winter; 18 (4):223-32
    View PubMed
  198. Larson JS, Bergstrom LK, Cameron JD, Erickson LA, Grimm TE. Severe periorbital edema secondary to imatinib mesylate for chronic myelogenous leukemia. Arch Ophthalmol. 2007 Jul; 125(7):985-6.
    View PubMed
  199. Markovic SN, Suman VJ, Rao RA, Ingle JN, Kaur JS, Erickson LA, Pitot HC, Croghan GA, McWilliams RR, Merchan J, Kottschade LA, Nevala WK, Uhl CB, Allred J, Creagan ET. A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma. Am J Clin Oncol. 2007 Jun; 30 (3):303-9
    View PubMed
  200. Erickson LA, Jin L, Nakamura N, Bridges AG, Markovic SN, Lloyd RV. Clinicopathologic features and BRAF(V600E) mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas. Cancer. 2007 May 15; 109(10):1965-71.
    View PubMed
  201. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET, Melanoma Study Group of Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc. 2007 Apr; 82 (4):490-513
    View PubMed
  202. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET, Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007 Mar; 82 (3):364-80
    View PubMed
  203. Zhang HY, Rumilla KM, Jin L, Nakamura N, Stilling GA, Ruebel KH, Hobday TJ, Erlichman C, Erickson LA, Lloyd RV. Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors. Endocrine. 2006 Dec; 30 (3):299-306
    View PubMed
  204. Shors AR, Kim S, White E, Argenyi Z, Barnhill RL, Duray P, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Rabkin MS, Schmidt B, Shea CR, Trotter MJ, Piepkorn MW. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol. 2006 Nov; 155(5):988-93.
    View PubMed
  205. Rumilla KM, Erickson LA, Erickson AK, Lloyd RV. Galectin-4 expression in carcinoid tumors. Endocr Pathol. 2006 Fall; 17 (3):243-9
    View PubMed
  206. Nakamura N, Erickson LA, Jin L, Kajita S, Zhang H, Qian X, Rumilla K, Lloyd RV. Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma. Endocr Pathol. 2006 Fall; 17 (3):213-23
    View PubMed
  207. Chow LS, Erickson LA, Abu-Lebdeh HS, Wermers RA. Parathyroid lipoadenomas: a rare cause of primary hyperparathyroidism. Endocr Pract. 2006 Mar-Apr; 12 (2):131-6
    View PubMed
  208. Papouchado B, Erickson LA, Rohlinger AL, Hobday TJ, Erlichman C, Ames MM, Lloyd RV. Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas. Mod Pathol. 2005 Oct; 18 (10):1329-35
    View PubMed
  209. Nakamura N, Carney JA, Jin L, Kajita S, Pallares J, Zhang H, Qian X, Sebo TJ, Erickson LA, Lloyd RV. RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors. Lab Invest. 2005 Sep; 85 (9):1065-75
    View PubMed
  210. Erickson LA, Lloyd RV, Hartman R, Thompson G. Cystic adrenal neoplasms. Cancer. 2004 Oct 1; 101 (7):1537-44
    View PubMed
  211. Erickson LA, Myers JL, Mihm MC, Markovic SN, Pittelkow MR. Malignant basomelanocytic tumor manifesting as metastatic melanoma. Am J Surg Pathol. 2004 Oct; 28 (10):1393-6
    View PubMed
  212. Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, Chan JK, DeLellis RA, Harach HR, Kakudo K, LiVolsi VA, Rosai J, Sebo TJ, Sobrinho-Simoes M, Wenig BM, Lae ME. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004 Oct; 28 (10):1336-40
    View PubMed
  213. Erickson LA, Papouchado B, Dimashkieh H, Zhang S, Nakamura N, Lloyd RV. Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. Endocr Pathol. 2004 Fall; 15 (3):247-52
    View PubMed
  214. Erickson LA, Lloyd RV. Practical markers used in the diagnosis of endocrine tumors. Adv Anat Pathol. 2004 Jul; 11 (4):175-89
    View PubMed
  215. Erickson LA, Jalal SM, Harwood A, Shearer B, Jin L, Lloyd RV. Analysis of parathyroid neoplasms by interphase fluorescence in situ hybridization. Am J Surg Pathol. 2004 May; 28 (5):578-84
    View PubMed
  216. Erickson LA. Polymorphous light reaction and chronic photosensitivity. Pathology International. 2004; 54(S1):S566-S569.
  217. Erickson LA, Papotti M, Volante M, Jin L, Lewis JE, Lloyd RV. Merkel cell carcinomas: expression of S-phase kinase-associated protein 2 (Skp2), p27, and proliferation markers. Endocr Pathol. 2003 Fall; 14 (3):221-29
    View PubMed
  218. Gaffney RL, Carney JA, Sebo TJ, Erickson LA, Volante M, Papotti M, Lloyd RV. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. Am J Surg Pathol. 2003 Apr; 27 (4):494-8
    View PubMed
  219. O'Sullivan BP, Erickson LA, Niles JL. Case records of the Massachusetts General Hospital. Weekly clinicopathologic exercises. Case 30-2002. An eight-year-old girl with fever, hemoptysis, and pulmonary consolidations. (Clinical Conference. Journal Article). N Engl J Med. 2002 Sept 26; 347(13):1009-17.
    View PubMed
  220. Erickson LA, Jin L, Papotti M, Lloyd RV. Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases. Am J Surg Pathol. 2002 Mar; 26 (3):344-9
    View PubMed
  221. Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV. Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol. 2001 Dec; 25(12):1478-84.
    View PubMed
  222. Erickson LA, Jin L, Sebo TJ, Lohse C, Pankratz VS, Kendrick ML, van Heerden JA, Thompson GB, Grant CS, Lloyd RV. Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms. Endocr Pathol. 2001 Winter; 12 (4):429-35
    View PubMed
  223. Erickson LA, Jalal SM, Goellner JR, Law ME, Harwood A, Jin L, Roche PC, Lloyd RV. Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization. Am J Surg Pathol. 2001 Jul; 25 (7):911-7
    View PubMed
  224. Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Lloyd RV. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol. 2001 Jun; 25 (6):815-9
    View PubMed
  225. Kendrick ML, Lloyd R, Erickson L, Lloyd R, Erickson L, Farley DR, Grant CS, Thompson GB, Rowland C, Rowland C, Young WF Jr, van Heerden JA. Adrenocortical carcinoma: surgical progress or status quo? Arch Surg. 2001 May; 136 (5):543-9
    View PubMed
  226. Lloyd RV, Erickson LA. Cell cycle (cancer). pp. 83-86, 2001. In: McGraw-Hill Yearbook of Science & Technology. 2001. McGraw-Hill, New York, NY. 2001.
  227. Erickson LA, Yousef OM, Jin L, Lohse CM, Pankratz VS, Lloyd RV. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma. Mod Pathol. 2000 Sep; 13 (9):1014-9
    View PubMed
  228. Erickson LA, Jin L, Goellner JR, Lohse C, Pankratz VS, Zukerberg LR, Thompson GB, van Heerden JA, Grant CS, Lloyd RV. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid. Mod Pathol. 2000 Feb; 13(2):186-92.
    View PubMed
  229. Oliveira AM, Erickson LA, Burgart LJ, Lloyd RV. Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA. Am J Surg Pathol. 2000 Feb; 24 (2):177-82
    View PubMed
  230. Erickson LA. p27(kip1) and other cell-cycle protein expression in normal and neoplastic endocrine tissues. Endocr Pathol. 2000 Sum; 11(2):109-122.
    View PubMed
  231. Erickson L, Yousef O, Jin L, Lohse C, Pankratz V, Lloyd R. P27(kip1) expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma. Mod Pathol. 2000; 13(9):1014-1019.
  232. Erickson LA, Jin L, Wollan P, Thompson GB, van Heerden JA, Lloyd RV. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. Am J Surg Pathol. 1999 Mar; 23 (3):288-95
    View PubMed
  233. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, Scheithauer BW. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999 Feb; 154 (2):313-23
    View PubMed
  234. Lloyd RV, Erickson LA, Nascimento AG, Kloppel G. Neoplasms causing nonhyperinsulinemic hypoglycemia. Endocr Pathol. 1999 Win; 10(4):291-297.
    View PubMed
  235. Erickson LA, Lloyd RV, Cheville JC. The p27 protein as a diagnostic and prognostic marker in prostate cancer. Current Topics in Clinical Medicine. 1999; 2(3):53-5.
  236. Imamura Y, Jin L, Grande JP, Li CY, Zheng TR, Erickson LA, Lloyd RV. Analysis of TGF-beta and TGF-beta-RII in thyroid neoplasms from the United States, Japan, and China. Endocr Pathol. 1998 Fal; 9(3):209-216.
    View PubMed
  237. Cheville JC, Lloyd RV, Sebo TJ, Cheng L, Erickson L, Bostwick DG, Lohse CM, Wollan P. Expression of p27kip1 in prostatic adenocarcinoma. Mod Pathol. 1998 Apr; 11(4):324-8.
    View PubMed
  238. Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol. 1998 Feb; 11(2):169-74.
    View PubMed
  239. Cheville J, Lloyd R, Sebo T, Cheng L, Erickson L, Bostwick D, Lohse C, Wollan P. Expression of p27(kip1) in prostatic adenocarcinoma. Mod Pathol. 1998; 11(4):324-328.